Works by Timme, T. L.

Results: 9

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Published in:
Prostate Cancer & Prostatic Diseases, 2002, v. 5, n. 4, p. 316, doi. 10.1038/sj.pcan.4500610
By:
- Ebara, S;
- Shimura, S;
- Nasu, Y;
- Kaku, H;
- Kumon, H;
- Yang, G;
- Wang, J;
- Timme, T L;
- Aguilar-Cordova, E;
- Thompson, T C
Publication type:
Article
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer.
Published in:
Prostate Cancer & Prostatic Diseases, 2001, v. 4, n. 1, p. 44, doi. 10.1038/sj.pcan.4500494
By:
- Nasu, Y;
- Bangma, C H;
- Hull, G W;
- Yang, G;
- Wang, J;
- Shimura, S;
- McCurdy, M A;
- Ebara, S;
- Lee, H-M;
- Timme, T L;
- Thompson, T C
Publication type:
Article
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.
Published in:
Cancer Gene Therapy, 2007, v. 14, n. 10, p. 819, doi. 10.1038/sj.cgt.7701069
By:
- Wang, H.;
- Yang, G.;
- Timme, T. L.;
- Fujita, T.;
- Naruishi, K.;
- Frolov, A.;
- Brenner, M. K.;
- Kadmon, D.;
- Thompson, T. C.
Publication type:
Article
IL-12 gene-modified bone marrow cell therapy suppresses the development of experimental metastatic prostate cancer.
Published in:
2007
By:
- Wang, H.;
- Yang, G.;
- Timme, T. L.;
- Fujita, T.;
- Naruishi, K.;
- Frolov, A.;
- Brenner, M. K.;
- Kadmon, D.;
- Thompson, T. C.
Publication type:
Correction Notice
Adenoviral vector-mediated RTVP-1 gene-modified tumor cell-based vaccine suppresses the development of experimental prostate cancer.
Published in:
Cancer Gene Therapy, 2006, v. 13, n. 7, p. 658, doi. 10.1038/sj.cgt.7700919
By:
- Naruishi, K.;
- Timme, T. L.;
- Kusaka, N.;
- Fujita, T.;
- Yang, G.;
- Goltsov, A.;
- Satoh, T.;
- Ji, X.;
- Tian, W.;
- Abdelfattah, E.;
- Men, T.;
- Watanabe, M.;
- Tabata, K.;
- Thompson, T. C.
Publication type:
Article
Therapeutic effects of adoptive splenocyte transfer following in situ AdIL-12 gene therapy in a mouse prostate cancer model.
Published in:
Cancer Gene Therapy, 2006, v. 13, n. 1, p. 91, doi. 10.1038/sj.cgt.7700872
By:
- Saika, T.;
- Kusaka, N.;
- Mouraviev, V.;
- Satoh, T.;
- Kumon, H.;
- Timme, T. L.;
- Thompson, T. C.
Publication type:
Article
DNA ploidy and clonal selection in ras + myc - Induced mouse prostate cancer.
Published in:
International Journal of Cancer, 1995, v. 60, n. 3, p. 395, doi. 10.1002/ijc.2910600321
By:
- Greene, D. R.;
- Taylor, S. R.;
- Aihara, M.;
- Yoshida, K.;
- Egawa, S.;
- Park, S. H.;
- Timme, T. L.;
- Yang, G.;
- Scardino, P. T.;
- Thompson, T. C.
Publication type:
Article
Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
Published in:
Gene Therapy, 2007, v. 14, n. 3, p. 227, doi. 10.1038/sj.gt.3302788
By:
- Fujita, T.;
- Timme, T. L.;
- Tabata, K.;
- Naruishi, K.;
- Kusaka, N.;
- Watanabe, M.;
- Abdelfattah, E.;
- Zhu, J. X.;
- Ren, C.;
- Yang, G.;
- Goltsov, A.;
- Wang, H.;
- Vlachaki, M. T.;
- Teh, B. S.;
- Butler, E. B.;
- Thompson, T. C.
Publication type:
Article
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
Published in:
Gene Therapy, 1999, v. 6, n. 3, p. 338, doi. 10.1038/sj.gt.3300834
By:
- Nasu, Y;
- Bangma, C H;
- Hull, G W;
- Lee, H-M;
- Hu, J;
- Wang, J;
- McCurdy, M A;
- Shimura, S;
- Yang, G;
- Timme, T L;
- Thompson, T C
Publication type:
Article